IgG Epitopes Processed and Presented by IgG+ B Cells Induce Suppression by Human Thymic-Derived Regulatory T Cells

Key Points IgG1 Fc peptides activate natural Treg, which regulate naive T cell differentiation. Ag processing of the surface IgG on B cells activates Treg. We described a human regulatory T cell (Treg) population activated by IgG+ B cells presenting peptides of the heavy C region (Fc) via processing of the surface IgG underlying a model for B cell–Treg cooperation in the human immune regulation. Functionally, Treg inhibited the polarization of naive T cells toward a proinflammatory phenotype in both a cognate and a noncognate fashion. Their fine specificities were similar in healthy donors and patients with rheumatoid arthritis, a systemic autoimmune disease. Four immunodominant Fc peptides bound multiple HLA class II alleles and were recognized by most subjects in the two cohorts. The presentation of Fc peptides that stimulate Treg through the processing of IgG by dendritic cells (DC) occurred in myeloid DC classical DC 1 and classical DC 2. Different routes of Ag processing of the IgG impacted Treg expansion in rheumatoid arthritis patients.

[1]  W. Frishman,et al.  Multisystem Inflammatory Syndrome , 2022, Cardiology in review.

[2]  K. Sullivan,et al.  Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS-CoV-2. , 2020, The Journal of clinical investigation.

[3]  Simon Li,et al.  Multisystem Inflammatory Syndrome in U.S. Children and Adolescents , 2020, The New England journal of medicine.

[4]  David R. Holtgrave,et al.  Multisystem Inflammatory Syndrome in Children in New York State , 2020, The New England journal of medicine.

[5]  D. Glass,et al.  T regulatory cells mediate specific suppression by depleting peptide-MHC class II from dendritic cells , 2018, Nature Immunology.

[6]  B. Becher,et al.  T cells in patients with narcolepsy target self-antigens of hypocretin neurons , 2018, Nature.

[7]  J. Sidney,et al.  Regulatory CD4+ T Cells Recognize Major Histocompatibility Complex Class II Molecule– Restricted Peptide Epitopes of Apolipoprotein B , 2018 .

[8]  D. Hafler,et al.  Regulatory T cells in autoimmune disease , 2018, Nature Immunology.

[9]  D. Neri,et al.  Membranal and Blood‐Soluble HLA Class II Peptidome Analyses Using Data‐Dependent and Independent Acquisition , 2018, Proteomics.

[10]  Matthew Collin,et al.  Human dendritic cell subsets: an update , 2018, Immunology.

[11]  Allon M Klein,et al.  Single-cell gene expression reveals a landscape of regulatory T cell phenotypes shaped by the TCR , 2018, Nature Immunology.

[12]  Oliver Kohlbacher,et al.  HLA ligandome analysis of primary chronic lymphocytic leukemia (CLL) cells under lenalidomide treatment confirms the suitability of lenalidomide for combination with T-cell-based immunotherapy , 2017, Oncoimmunology.

[13]  J. Ravetch,et al.  Fcγ Receptor Function and the Design of Vaccination Strategies. , 2017, Immunity.

[14]  Evan W. Newell,et al.  Mapping the human DC lineage through the integration of high-dimensional techniques , 2017, Science.

[15]  C. Dossier,et al.  Intravenous Immunoglobulin Therapy in Pediatric Narcolepsy: A Nonrandomized, Open-Label, Controlled, Longitudinal Observational Study. , 2017, Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.

[16]  S. Shen-Orr,et al.  Social network architecture of human immune cells unveiled by quantitative proteomics , 2017, Nature Immunology.

[17]  N. McGovern,et al.  Human lymphoid organ dendritic cell identity is predominantly dictated by ontogeny, not tissue microenvironment , 2016, Science Immunology.

[18]  C. Leslie,et al.  Memory of Inflammation in Regulatory T Cells , 2016, Cell.

[19]  D. Hafler,et al.  Multiple sclerosis: genetics, biomarkers, treatments. , 2016, Current opinion in neurology.

[20]  J. Sidney,et al.  Fine specificities of natural regulatory T cells after IVIG therapy in patients with Kawasaki disease , 2015, Autoimmunity.

[21]  Morten Nielsen,et al.  Different binding motifs of the celiac disease-associated HLA molecules DQ2.5, DQ2.2, and DQ7.5 revealed by relative quantitative proteomics of endogenous peptide repertoires , 2014, Immunogenetics.

[22]  J. Kanegaye,et al.  Specificity of regulatory T cells that modulate vascular inflammation , 2014, Autoimmunity.

[23]  Shimon Sakaguchi,et al.  The plasticity and stability of regulatory T cells , 2013, Nature Reviews Immunology.

[24]  Clemencia Pinilla,et al.  Measurement of MHC/Peptide Interactions by Gel Filtration or Monoclonal Antibody Capture , 2013, Current protocols in immunology.

[25]  W. Oertel,et al.  Intravenous Immunoglobulins as a Treatment for Alzheimer’s Disease , 2010, Drugs.

[26]  J. Cedano,et al.  The peptide-binding motif of HLA-DR8 shares important structural features with other type 1 diabetes-associated alleles , 2011, Genes and Immunity.

[27]  Bjoern Peters,et al.  Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes , 2011, Immunogenetics.

[28]  D. Scott,et al.  Activation of natural regulatory T cells by IgG Fc-derived peptide "Tregitopes". , 2008, Blood.

[29]  Cisca Wijmenga,et al.  Association analysis of functional variants of the FcgRIIa and FcgRIIIa genes with type 1 diabetes, celiac disease and rheumatoid arthritis. , 2007, Human molecular genetics.

[30]  L. V. D. van de Putte,et al.  Role of Fcgamma receptors IIA, IIIA, and IIIB in susceptibility to rheumatoid arthritis. , 2003, The Journal of rheumatology.

[31]  J. Allison,et al.  ICOS co-stimulatory receptor is essential for T-cell activation and function , 2001, Nature.

[32]  A Sette,et al.  Two complementary methods for predicting peptides binding major histocompatibility complex molecules. , 1997, Journal of molecular biology.

[33]  R. de Waal Malefyt,et al.  Interleukin-10 down-regulates MHC class II alphabeta peptide complexes at the plasma membrane of monocytes by affecting arrival and recycling. , 1997, Immunity.

[34]  A. Lanzavecchia,et al.  Processed antigen binds to newly synthesized mhc class II molecules in antigen-specific B lymphocytes , 1991, Cell.

[35]  V. Barnaba,et al.  Selective killing of hepatitis B envelope antigen-specific B cells by class I-restricted, exogenous antigen-specific T lymphocytes , 1990, Nature.

[36]  P. Cresswell,et al.  Co-localization of molecules involved in antigen processing and presentation in an early endocytic compartment , 1990, Nature.

[37]  D E Trentham,et al.  The immunopathogenesis of rheumatoid arthritis. , 1985, The Journal of rheumatology. Supplement.

[38]  Y. Cheng,et al.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.